Alexion Pharmaceuticals, Inc.
ALXNDelisted Jul 21, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000899866
Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 712 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 712
- Q2 2021, −35 vs. previous quarter
- 13F value
- $39.1B
- Reported value at the end of Q2 2021
- Superinvestors holding
- 2
- At the end of Q2 2021
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2020
- $6.07B
- +21.6% year over year
- Net income, FY2020
- $603.4M
- −74.9% year over year
- Free cash flow, FY2020
- $2.90B
- +50.0% year over year
- Revenue, Q1 FY2021
- $1.64B
- +13.3% year over year
Revenue flow, FY2020
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Superinvestors holding ALXN, Q2 2021
Go to the superinvestors tab2 superinvestors report holding Alexion Pharmaceuticals, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Soros Fund Management
George Soros
1.7%
Alexion Pharmaceuticals, Inc.'s share of the portfolio
- Shares
- 500,001
- Value
- $91.9M
Maverick Capital
Lee Ainslie
<0.1%
Alexion Pharmaceuticals, Inc.'s share of the portfolio
- Shares
- 11,420
- Value
- $2.10M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Alexion Pharmaceuticals, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Alexion Pharmaceuticals, Inc. insiders are on file.
Top 10 13F holders, Q2 2021
See all 712 holdersThe largest institutional positions in Alexion Pharmaceuticals, Inc. at the end of Q2 2021; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 20,367,300 | $3.74B | 0.09% | +798,317+4.1% | Added |
| BlackRock Inc. | 17,495,607 | $3.21B | 0.09% | −54,688−0.3% | Reduced |
| State Street Corp | 10,033,808 | $1.84B | 0.10% | +156,274+1.6% | Added |
| Farallon Capital Management, L.L.C. | 7,707,500 | $1.42B | 6.83% | +1,932,500+33.5% | Added |
| HBK Investments L P | 6,600,000 | $1.21B | 11.63% | +875,000+15.3% | Added |
| Davidson Kempner Capital Management LP | 5,473,378 | $1.01B | 7.84% | +1,409,202+34.7% | Added |
| Adage Capital Partners GP, L.L.C. | 5,238,014 | $962.3M | 1.88% | +995,635+23.5% | Added |
| Pentwater Capital Management LP | 4,933,200 | $906.3M | 9.31% | +643,956+15.0% | Added |
| Millennium Management LLC | 4,829,380 | $887.2M | 1.14% | +2,276,841+89.2% | Added |
| UBS Oconnor LLC | 4,428,122 | $813.5M | 7.28% | +2,861,349+182.6% | Added |
Politician trades
All politician trades in ALXN3 members of Congress reported 12 trades in Alexion Pharmaceuticals, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 14, 2021 | James R. Langevin House · RI | Sell | $15K-$50K |
| Aug 13, 2021 | Dean Phillips House · MN | Sell | $1K-$15K |
| Feb 13, 2021 | Dean Phillips House · MN | Buy | $1K-$15K |
| Jan 11, 2021 | Gilbert Ray Cisneros, Jr. House · CA | Sell (partial) | $50K-$100K |
| Jan 11, 2021 | Gilbert Ray Cisneros, Jr. House · CA | Sell (partial) | $15K-$50K |

House · RI · Aug 14, 2021
Sell$15K-$50K

House · MN · Aug 13, 2021
Sell$1K-$15K

House · MN · Feb 13, 2021
Buy$1K-$15K

House · CA · Jan 11, 2021
Sell (partial)$50K-$100K

House · CA · Jan 11, 2021
Sell (partial)$15K-$50K